The U.S. Supreme Court’s recent game-changing decision in Bristol-Myers Squibb v. Superior Court of California is widely seen as the beginning of the end for mass torts in several venues that have historically attracted large-scale litigation, including California and Missouri.

But, for Pennsylvania—another state with significant mass tort dockets—the ruling is expected to be much more of a mixed bag, and, according to some, could instead lead to an uptick in suits against certain defendants.